Guardion Health Sciences, Inc.

    Jurisdiction
    United States
    LEI
    5493001V8N461H1N6381
    ISIN
    US40145Q5009 (GHSI)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. Read full profile

    Fundamentals

    Net revenue
    €7.97M
    Gross margin
    43.0%
    EBIT
    -€3.30M
    EBIT margin
    -41.4%
    Net income
    €5.44M
    Net margin
    68.2%

    Statement period: - (published )

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $3.25
    Ex date

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    No insider transactions in the last 90 days. View older insider transactions

    Earnings Calls

    Earnings Calls

    Latest earnings call: August 12, 2020 (Q2 2020)

    Add to watchlist

    Notifications